Differential effect of intrauterine growth restriction on childhood neurodevelopment: a systematic review
- PMID: 25990812
- DOI: 10.1111/1471-0528.13435
Differential effect of intrauterine growth restriction on childhood neurodevelopment: a systematic review
Abstract
Background: Neurodevelopmental disorders are increasingly believed to originate from intrauterine growth restriction (IUGR). Current reviews exploring the neurodevelopmental effects of IUGR, however, are mostly based on birthweight, an inadequate proxy.
Objective: We aimed to examine the association between IUGR documented in utero, and neurodevelopmental outcomes during childhood.
Search strategy: Medline, CINAHL, PsycInfo and Scopus were searched for relevant studies published after 1970.
Selection criteria: The analysis included studies that identified IUGR in utero, with follow-up assessments between 1 month and 12 years of age.
Data collection and analysis: Data was extracted for cognitive, behavioural, language, motor, hearing, vision or sleep outcomes. Studies were summarised separately for children born at <35 and ≥35 weeks gestation.
Main results: Of 28 876 titles identified, 38 were suitable for inclusion. IUGR children born ≥35 weeks gestation scored on average 0.5 SD lower than non-IUGR children across all neurodevelopmental assessments. IUGR children born <35 weeks of gestation scored approximately 0.7 SD lower than non-IUGR children across all neurodevelopmental assessments. IUGR children with evidence of fetal circulatory redistribution (preferential perfusion of the brain) had more severe neurodevelopmental impairments than those born IUGR alone.
Conclusions: IUGR increases the risk of neurodevelopmental impairment during childhood differentially across domains. IUGR children born preterm or with evidence of fetal circulatory redistribution are more severely affected.
Tweetable abstract: IUGR is associated with an overall risk for neurodevelopmental delay in a range of neurodevelopmental domains.
Keywords: Doppler velocimetry; fetal growth retardation; intrauterine growth restriction; neurodevelopment; serial ultrasound biometry; small-for-gestational-age.
© 2015 Royal College of Obstetricians and Gynaecologists.
Comment in
-
Re: Differential effect of intrauterine growth restriction on childhood neurodevelopment: a systematic review.BJOG. 2015 Dec;122(13):1850. doi: 10.1111/1471-0528.13705. BJOG. 2015. PMID: 26589866 No abstract available.
Similar articles
-
Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.Cochrane Database Syst Rev. 2015 Nov 24;2015(11):CD009433. doi: 10.1002/14651858.CD009433.pub2. Cochrane Database Syst Rev. 2015. PMID: 26599471 Free PMC article.
-
Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants.Cochrane Database Syst Rev. 2024 Feb 13;2(2):CD005495. doi: 10.1002/14651858.CD005495.pub5. Cochrane Database Syst Rev. 2024. PMID: 38348930 Free PMC article.
-
Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants.Cochrane Database Syst Rev. 2015 Nov 24;2015(11):CD005495. doi: 10.1002/14651858.CD005495.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2024 Feb 13;2:CD005495. doi: 10.1002/14651858.CD005495.pub5. PMID: 26597166 Free PMC article. Updated.
-
Early childhood neurodevelopment after intrauterine growth restriction: a systematic review.Pediatrics. 2015 Jan;135(1):126-41. doi: 10.1542/peds.2014-1143. Pediatrics. 2015. PMID: 25548332
-
Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.Cochrane Database Syst Rev. 2022 Apr 4;4(4):CD003935. doi: 10.1002/14651858.CD003935.pub5. Cochrane Database Syst Rev. 2022. PMID: 35377461 Free PMC article.
Cited by
-
Animal Foetal Models of Obesity and Diabetes - From Laboratory to Clinical Settings.Front Endocrinol (Lausanne). 2022 Feb 7;13:785674. doi: 10.3389/fendo.2022.785674. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35197931 Free PMC article. Review.
-
Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb).BMJ Open. 2022 Jun 14;12(6):e054925. doi: 10.1136/bmjopen-2021-054925. BMJ Open. 2022. PMID: 35701067 Free PMC article.
-
Patterns of Fetal and Infant Growth and Brain Morphology at Age 10 Years.JAMA Netw Open. 2021 Dec 1;4(12):e2138214. doi: 10.1001/jamanetworkopen.2021.38214. JAMA Netw Open. 2021. PMID: 34882181 Free PMC article.
-
A multicountry randomized controlled trial of comprehensive maternal nutrition supplementation initiated before conception: the Women First trial.Am J Clin Nutr. 2019 Feb 1;109(2):457-469. doi: 10.1093/ajcn/nqy228. Am J Clin Nutr. 2019. PMID: 30721941 Free PMC article. Clinical Trial.
-
Human placental villous stromal extracellular matrix regulates fetoplacental angiogenesis in severe fetal growth restriction.Clin Sci (Lond). 2021 May 14;135(9):1127-1143. doi: 10.1042/CS20201533. Clin Sci (Lond). 2021. PMID: 33904582 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical